📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-13 21:09
453 analysed today
453
Today
133,342
All-time analysed
40,106
Positive
6,279
Negative
79,144
Neutral
7,745
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
38 announcements match the current filters (relevance ≥ 5).
Halder Venture Q1 Revenue up 69% YoY; Auditors flag Rs 66.8 Cr non-moving inventory
Halder Venture reported a strong 68.7% YoY growth in standalone revenue to Rs 180.01 Cr for Q1 FY27, with net profit rising 42.7% to Rs 5.61 Cr. However, the statutory auditors highlighted significant concerns regarding Rs 66.83 Cr of inventory (Rice and Rice Bran Oil) that has been non-moving for over two years and is still carried at cost. The Edible Oil segment has become the primary driver, contributing 76.8% of consolidated revenue, while the Rice segment reported a loss of Rs 2.02 Cr at the segment result level.
Confidence: HIGH
What changedThe company has shown significant revenue growth driven by its Edible Oil segment, but auditors have raised formal concerns regarding inventory valuation and asset depreciation methods.
Why it mattersThe flagged non-moving inventory represents approximately 27.7% of the company's current market capitalization, making its realization value critical for the company's net worth and future earnings.
Standalone Revenue (Q1 FY27): Rs 180.01 CrStandalone Net Profit (Q1 FY27): Rs 5.61 CrNon-moving Inventory Value: Rs 66.83 CrInventory vs Market Cap: 27.7%Oil Segment Revenue Share: 76.8%
📅 Short termThe market may react positively to the top-line growth, but the auditor's emphasis of matter regarding legacy inventory and depreciation could cap gains as it introduces valuation uncertainty.
📈 Long termStructural growth depends on the successful scaling of the Edible Oil business and the resolution of legacy asset issues inherited from liquidations.
⚠ Risk flags
- Inventory write-down risk (Rs 66.83 Cr non-moving for 2+ years)
- Auditor qualification on depreciation of old plant assets
- Loss-making Rice segment (Rs 2.02 Cr loss in Q1)
- High finance costs relative to operating margins
Key Highlights
Standalone revenue increased to Rs 180.01 Cr from Rs 106.72 Cr in the same quarter last year.
Edible Oil segment revenue grew to Rs 143.71 Cr, now representing 76.8% of gross consolidated revenue.
Auditors flagged Rs 38.98 Cr of rice and Rs 27.85 Cr of rice bran oil inventory as non-moving for over two years.
Standalone net profit for the quarter stood at Rs 5.61 Cr compared to Rs 3.93 Cr in Q1 FY26.
Finance costs remained elevated at Rs 9.07 Cr for the quarter, representing ~5% of standalone revenue.
👀 What to Watch
Investors should closely monitor the management's progress in liquidating the Rs 66.83 Cr non-moving inventory, as any significant write-down would impact the bottom line. Additionally, watch for the technical evaluation of the old plant assets (Rs 1.43 Cr) acquired from K.S. Oils, expected by the next quarter.
Halder Venture Q1 Revenue Grows 69% to ₹180 Cr; Auditor Flags ₹66.8 Cr Stale Inventory
Halder Venture reported a strong 68.7% YoY growth in standalone revenue to ₹180.01 Cr for Q1 FY27, with net profit rising 42.7% to ₹5.61 Cr. However, the auditor's report highlights significant concerns regarding ₹66.83 Cr of non-moving inventory (Rice and Rice Bran Oil) held for over two years at cost. The auditor noted a lack of evidence that the net realizable value of this inventory meets its cost, posing a potential write-down risk. Additionally, the company is depreciating ₹1.43 Cr of old machinery as new assets, which may be understating depreciation expenses.
Confidence: HIGH
What changedThe company showed significant scaling in its Edible Oil segment but continues to carry large amounts of non-moving inventory from over two years ago.
Why it mattersThe flagged stale inventory of ₹66.83 Cr represents approximately 19.3% of the company's TTM revenue, making any potential write-down highly material to the company's net worth and profitability.
Standalone Revenue (Q1 FY27): ₹180.01 CrStandalone PAT (Q1 FY27): ₹5.61 CrStale Inventory vs TTM Revenue: ~19.3%Total Stale Inventory Value: ₹66.83 CrEdible Oil Segment Revenue: ₹143.71 Cr
📅 Short termThe market may react positively to the top-line growth, but the auditor's emphasis on stale inventory and depreciation practices provides a cautionary backdrop.
📈 Long termWhile the shift toward the Edible Oil segment shows growth potential, the persistent issues with inventory management and asset valuation suggest internal control weaknesses that need addressing.
⚠ Risk flags
- Potential write-down of ₹66.83 Cr non-moving inventory
- Understated depreciation on ₹1.43 Cr of old machinery
- High finance costs relative to operating margins
Key Highlights
Standalone Revenue from operations increased 68.7% YoY to ₹180.01 Cr from ₹106.72 Cr.
Standalone Net Profit grew 42.7% YoY to ₹5.61 Cr compared to ₹3.93 Cr in the previous year.
Auditor flagged ₹38.98 Cr of rice inventory and ₹27.85 Cr of rice bran oil inventory non-moving for over two years.
Edible Oil segment revenue surged to ₹143.71 Cr, now contributing 75% of consolidated gross revenue.
Finance costs remained high at ₹9.07 Cr for the quarter, representing 5% of standalone revenue.
👀 What to Watch
Monitor management's progress in liquidating the ₹66.83 Cr stale inventory and watch for any impairment charges in upcoming quarters. Investors should also look for the technical evaluation of old plant assets expected by next quarter to see if depreciation is adjusted.
Halder Venture Q1 Revenue up 69% YoY; Auditor flags Rs 66.8 Cr non-moving inventory
Halder Venture reported a strong 68.7% YoY growth in standalone revenue to Rs 180.01 Cr for Q1 FY27, primarily driven by the Edible Oil segment. Standalone Net Profit increased by 42.7% YoY to Rs 5.61 Cr. However, the statutory auditor has issued a significant 'Emphasis of Matter' regarding Rs 66.83 Cr of inventory (Rice and Rice Bran Oil) that has been non-moving for over two years and is still carried at cost. Additionally, the auditor noted that depreciation on acquired old machinery (Rs 1.43 Cr) may be understated as it is being treated as new equipment.
Confidence: HIGH
What changedThe company has shifted its revenue mix heavily toward Edible Oils, but the statutory auditor has formally highlighted valuation risks regarding legacy inventory and asset depreciation.
Why it mattersThe non-moving inventory represents approximately 19.3% of the company's TTM revenue (Rs 346 Cr), posing a material risk to the balance sheet and future profitability if the market value is lower than the recorded cost.
Standalone Revenue (Q1 FY27): Rs 180.01 CrStandalone PAT (Q1 FY27): Rs 5.61 CrNon-moving Inventory: Rs 66.83 CrInventory vs TTM Revenue: ~19.3%Edible Oil Segment Revenue (Consol): Rs 143.71 CrFinance Costs (Q1 FY27): Rs 9.07 Cr
📅 Short termThe strong top-line growth may provide initial positive momentum, but the auditor's observations regarding inventory and depreciation could lead to volatility as investors assess balance sheet quality.
📈 Long termThe structural shift to Edible Oils is evident, but long-term value depends on resolving legacy inventory issues and stabilizing margins, which remain thin at a TTM OPM of 2.2%.
⚠ Risk flags
- Inventory write-down risk (Rs 66.83 Cr non-moving for 2+ years)
- Understated depreciation on acquired assets
- Loss-making Rice segment
- High finance costs relative to operating profit
Key Highlights
Standalone Revenue grew 68.7% YoY to Rs 180.01 Cr from Rs 106.72 Cr in the previous year's quarter.
Standalone Net Profit rose 42.7% YoY to Rs 5.61 Cr, despite a significant increase in finance costs to Rs 9.07 Cr.
Auditors flagged Rs 66.83 Cr in non-moving inventory (Rice: Rs 38.98 Cr; Rice Bran Oil: Rs 27.85 Cr) held for over two years without NRV assessment.
Edible Oil segment revenue surged to Rs 143.71 Cr, while the Rice segment reported a loss of Rs 2.02 Cr at the segment result level.
Old plant and machinery worth Rs 1.43 Cr acquired from K.S. Oils is being depreciated over standard new-asset life, potentially understating expenses.
👀 What to Watch
Investors should closely monitor the management's progress in liquidating the Rs 66.83 Cr non-moving inventory and watch for any potential write-downs in upcoming quarters. The technical evaluation of the acquired K.S. Oils assets, expected by next quarter, will clarify if depreciation charges need to be adjusted upwards.
Halder Venture Seeks Shareholder Approval for Rs 1,000 Cr Borrowing and Investment Limits
Halder Venture Limited has issued a notice for its 44th Annual General Meeting (AGM) on September 7, 2026. The most significant agenda item is a proposal to increase both borrowing limits and investment/loan limits to Rs 1,000 Crores each, which is nearly 3x the company's TTM revenue of Rs 346 Cr. Additionally, the company seeks to appoint new statutory auditors for a 5-year term and approve a commission of up to 1% of net profits for a Non-Executive Director. These moves signal a potential for massive capital expenditure or expansion relative to the company's current Rs 238 Cr market capitalization.
Confidence: HIGH
What changedThe company is seeking shareholder permission to significantly expand its financial headroom for borrowing and investing, moving from current levels to a cap of Rs 1,000 Crores.
Why it mattersThe proposed Rs 1,000 Cr limit is highly material as it represents ~420% of the company's current market cap and ~289% of its TTM revenue, suggesting a major shift in business scale or potential acquisitions.
Proposed Borrowing Limit: Rs 1,000 CroresProposed Investment Limit: Rs 1,000 CroresLimit vs TTM Revenue: ~289%Limit vs Market Cap: ~420%Director Commission Cap: 1% of net profits
📅 Short termThe market may react with caution or curiosity to the scale of the proposed limits; the immediate focus will be on the AGM outcome and management's justification for such high limits.
📈 Long termIf the company utilizes these limits for high-return projects, it could lead to a structural re-rating; however, the current low operating margin of 2.2% makes execution and interest coverage key risks.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High borrowing limit relative to current revenue and market cap
- Potential for significant debt-servicing burden
- Low operating margins (2.2%) may limit the ability to absorb high interest costs
Key Highlights
Proposed increase in borrowing limits to Rs 1,000 Crores under Section 180(1)(c).
Proposed increase in limits for loans, guarantees, and investments to Rs 1,000 Crores under Section 186.
Appointment of M/s P. Somani & Co. as Statutory Auditors for a 5-year term starting from this AGM.
Proposal to pay commission to Non-Executive Director Mrs. Poulomi Halder up to 1% of annual net profits.
Ratification of Rs 1,00,000 remuneration for Cost Auditors for FY 2026-27.
👀 What to Watch
Investors should monitor the voting results of the AGM on September 7, 2026, particularly for the special resolution on borrowing limits, and watch for any subsequent announcements regarding specific expansion projects or debt-raising plans.
Rs 25 Cr Fundraise: Halder Venture Allots 7.93 Lakh Warrants at 36% Premium
Halder Venture Limited has approved the allotment of 7,93,650 equity convertible warrants to P.K. Bio Link Private Limited, a non-promoter entity. The warrants are issued at Rs 315 each, which is a significant ~36% premium over the current market price of Rs 231. The total fundraise is valued at approximately Rs 25 crore, representing about 12.8% of the company's current market capitalization. The company has already received the mandatory 25% upfront subscription amount (approx. Rs 6.25 crore).
Confidence: HIGH
What changedThe company has successfully initiated a preferential fundraise from a non-promoter investor, securing an immediate capital inflow of approximately Rs 6.25 crore.
Why it mattersThis fundraise provides significant growth capital relative to the company's size (12.8% of market cap) and the high premium suggests strong external valuation support for the stock.
Total Warrants Allotted: 7,93,650Issue Price per Warrant: Rs 315Total Fundraise Value: Rs 25 CrFundraise vs Market Cap: ~12.8%Upfront Amount Received (25%): ~Rs 6.25 Cr
📅 Short termThe announcement is likely to be viewed positively by the market due to the substantial premium of the warrant price over the current market price.
📈 Long termIf the capital is deployed into high-margin agricultural processing or expansion, it could improve the current low OPM of 2.2% and drive earnings growth.
⚠ Risk flags
- Equity dilution of approximately 12-13% upon full conversion of warrants
- Concentration risk with a single non-promoter allottee
Key Highlights
Allotment of 7,93,650 equity convertible warrants to a non-promoter group entity
Issue price fixed at Rs 315 per warrant, including a premium of Rs 305
Total potential capital infusion of Rs 25 crore upon full conversion
Initial 25% of the subscription amount already received by the company
Warrant issue price represents a ~36% premium to the current market price of Rs 231
👀 What to Watch
Investors should monitor the company's disclosure regarding the specific use of these funds and the timeline for the remaining 75% payment and subsequent conversion into equity shares.
Rs 25 Cr Fundraise: HALDER Allots 7.93 Lakh Warrants at 36% Premium to CMP
Halder Venture Limited has approved the allotment of 7,93,650 equity convertible warrants to P.K. Bio Link Private Limited, a non-promoter entity. The warrants are priced at Rs 315 each, which is a significant 36.3% premium over the current market price of Rs 231. The total potential fundraise amounts to approximately Rs 25 crore, representing about 12.8% of the company's current market capitalization. The company has already received the mandatory 25% upfront subscription amount.
Confidence: HIGH
What changedThe company has initiated a significant preferential fundraise from a non-promoter investor through convertible warrants.
Why it mattersThe fundraise provides substantial growth capital (12.8% of market cap) and the high premium paid by the investor suggests strong internal valuation confidence despite recent stock price weakness.
Total Fundraise Value: Rs 25.00 CrIssue Price per Warrant: Rs 315Fundraise vs Market Cap: ~12.8%Premium to CMP: 36.3%Upfront Amount Received: 25%
📅 Short termThe announcement is likely to be viewed positively by the market due to the high premium of the allotment price compared to the current market price.
📈 Long termIf the capital is deployed into high-margin agricultural processing or expansion, it could improve the current low OPM of 2.2%, though it will lead to equity dilution upon conversion.
⚠ Risk flags
- Equity dilution for existing shareholders
- Remaining 75% of funds are contingent on the allottee exercising conversion rights
Key Highlights
Allotment of 7,93,650 convertible warrants at a price of Rs 315 per warrant
Total potential capital infusion of Rs 25.00 crore upon full conversion
Issue price includes a premium of Rs 305 per warrant over the face value of Rs 10
Company has received 25% of the subscription amount from the allottee, P.K. Bio Link Private Limited
Allotment price of Rs 315 is ~36% higher than the current market price of Rs 231
👀 What to Watch
Investors should monitor the company's future disclosures regarding the specific utilization of these funds and the timeline for the conversion of the remaining 75% of the warrant value.
Halder Venture Clarifies FY26 Audit; Discloses 6.61% Legal Violation & Rs 56 Cr Acquisition
Halder Venture Limited responded to an NSE query, confirming an unmodified audit opinion for FY26. The filing reveals a legal contravention where two subsidiaries hold a 6.61% stake (8,22,654 shares) in the parent company, which they are currently divesting. Materially, the company disclosed the acquisition of the Haldia Manufacturing Unit for Rs 56.14 crore and an additional development spend of Rs 44.30 crore. Furthermore, a preferential allotment of 7,93,650 convertible warrants at Rs 315 per warrant is underway to raise capital.
Confidence: HIGH
What changedThe company provided formal proof of its audit opinion filing and detailed a significant legal non-compliance regarding subsidiary shareholding.
Why it mattersThe Section 19 violation is a compliance risk, while the ~Rs 100 crore total investment in the Haldia unit is substantial relative to the company's Rs 195 crore market cap, indicating a major pivot or expansion.
Subsidiary Cross-holding: 6.61%Haldia Unit Acquisition Cost: Rs 56.14 crDevelopment Spend on Property: Rs 44.30 crWarrant Issue Price: Rs 315Acquisition vs TTM Revenue: 16.2%
📅 Short termThe stock may see volatility as the market weighs the legal non-compliance against the significant asset expansion and upcoming warrant dilution.
📈 Long termThe successful integration and scaling of the Haldia unit could structurally change the company's revenue profile, given the scale of investment relative to current operations.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Legal contravention of Section 19 of Companies Act
- Execution risk on the newly acquired Haldia unit
- Equity dilution from 7.93 lakh convertible warrants
Key Highlights
Subsidiaries hold 8,22,654 shares (6.61%) in contravention of Section 19 of the Companies Act 2013
Acquisition of Haldia Manufacturing Unit for Rs 56.14 crore, representing ~16% of TTM revenue
Total development expenditure of Rs 44.30 crore incurred on the new Haldia property as of March 2026
Preferential allotment of 7,93,650 convertible warrants at Rs 315 per warrant (approx. Rs 25 crore total)
Auditors issued an 'Emphasis of Matter' regarding the illegal cross-holding but no modified opinion
👀 What to Watch
Investors should monitor the timeline for the disposal of the 6.61% stake by subsidiaries to resolve the legal contravention and track the operationalization of the Haldia unit for revenue contribution.
Halder Venture: Credit Rating Upgraded to CRISIL BBB-/Stable for Rs 387.27 Cr Facilities
CRISIL has upgraded Halder Venture's long-term credit rating to 'BBB-/Stable' from 'BB+/Stable ISSUER NOT COOPERATING'. This upgrade applies to total bank loan facilities of Rs 387.27 crore, which is significant given the company's TTM revenue of Rs 346 crore. The short-term rating has been reassigned as 'CRISIL A3'. The removal of the 'Issuer Not Cooperating' status indicates improved transparency and better standing with financial institutions.
Confidence: HIGH
What changedThe company's credit rating migrated from a non-cooperative 'BB+' grade to an investment-grade 'BBB-' rating by CRISIL.
Why it mattersMoving into investment grade and out of 'non-cooperating' status improves the company's ability to negotiate better interest rates and access fresh capital, which is critical given its high debt-to-revenue ratio.
Total Bank Facilities: Rs 387.27 CrRated Debt vs TTM Revenue: ~112%Long Term Rating: CRISIL BBB-/StableProposed Term Loan: Rs 13.07 CrTTM Revenue: Rs 346 Cr
📅 Short termThe upgrade is likely to be viewed positively by the market in the short term as it validates the company's financial reporting and creditworthiness.
📈 Long termWhile the upgrade is a structural positive, the company's low operating margin (2.2%) and high debt relative to revenue remain key long-term monitoring points.
⚠ Risk flags
- High leverage (Debt exceeds TTM Revenue)
- Low operating margins (2.2%)
- Concentration of debt in Cash Credit facilities (Rs 316 Cr)
Key Highlights
Long-term rating upgraded to CRISIL BBB-/Stable from BB+/Stable (INC)
Total bank loan facilities rated at Rs 387.27 crore
Rated debt represents approximately 112% of the TTM revenue of Rs 346 crore
Short-term rating reassigned at CRISIL A3
Includes a proposed term loan of Rs 13.07 crore for future utilization
👀 What to Watch
Monitor upcoming quarterly results to see if this upgrade leads to a reduction in finance costs. Watch for the utilization of the Rs 13.07 crore proposed term loan as a signal for potential expansion.
Rs 25 Cr Fundraise: Halder Venture Receives In-Principle Approval for 7.93 Lakh Warrants
Halder Venture Limited has received in-principle approval from both NSE and BSE for the issuance of 7,93,650 convertible warrants. These warrants are to be issued to non-promoters on a preferential basis at a price not less than Rs 315 per warrant, representing a total capital infusion of approximately Rs 25 crore. This fundraise is significant as it represents nearly double the company's TTM PAT of Rs 13 crore. The warrants are convertible into equity shares of Rs 10 each on a 1:1 basis within the regulatory timeframe.
Confidence: HIGH
What changedThe company has secured the necessary regulatory 'in-principle' approvals from stock exchanges to proceed with its planned preferential issuance of convertible warrants.
Why it mattersA Rs 25 crore capital infusion is material for a company with a TTM revenue of Rs 346 crore and low margins, providing necessary liquidity for potential expansion or strengthening the balance sheet.
Warrants to be issued: 7,93,650Minimum Issue Price: Rs 315Estimated Fundraise: Rs 25 CrFundraise vs TTM Revenue: ~7.2%Fundraise vs TTM PAT: ~192%
📅 Short termThe stock may see positive sentiment as the regulatory hurdle for capital infusion is cleared, though the actual impact depends on the final allotment and investor profile.
📈 Long termThe structural impact depends on whether the management can deploy this capital to stabilize earnings, which have been volatile (ranging from a Rs 10.8 cr loss to a Rs 20.7 cr profit in recent quarters).
⚠ Risk flags
- Equity dilution for existing shareholders
- Low operating profit margin (2.2%)
- Historical earnings volatility
Key Highlights
Issuance of 7,93,650 warrants convertible into an equal number of equity shares.
Minimum issue price fixed at Rs 315 per warrant, totaling a fundraise of ~Rs 25 crore.
In-principle approvals received from NSE and BSE on July 09, 2026.
The allotment is targeted at non-promoter investors on a preferential basis.
Fundraise amount of Rs 25 crore is approximately 192% of the TTM PAT of Rs 13 crore.
👀 What to Watch
Investors should monitor the final allotment notification to identify the specific non-promoter entities and watch for subsequent disclosures regarding the utilization of these funds to improve the current 2.2% operating margins.
Rs 25 Cr Fundraise: Halder Venture Receives In-Principle Approval for 7.93 Lakh Warrants
Halder Venture Limited has received in-principle approval from both NSE and BSE to issue 7,93,650 convertible warrants on a preferential basis. The warrants are priced at a minimum of Rs 315 each, representing a total capital infusion of approximately Rs 25 crore. This fundraise is significant as it represents nearly 1.9x the company's TTM PAT of Rs 13 crore and about 7.2% of its TTM revenue. The warrants will be issued to non-promoter entities, which will lead to equity dilution upon conversion.
Confidence: HIGH
What changedThe company has moved from the proposal stage to receiving formal regulatory clearance from stock exchanges for its preferential warrant issue.
Why it mattersThe Rs 25 crore infusion provides essential liquidity and growth capital for a company that has shown significant earnings volatility, including a loss in the September 2025 quarter.
Warrants to be issued: 7,93,650Minimum Issue Price: Rs 315Estimated Fundraise: Rs 25 CrFundraise vs TTM Revenue: ~7.2%Fundraise vs TTM PAT: ~192%
📅 Short termThe news is likely to be viewed positively by the market as it confirms the progress of a substantial capital raise.
📈 Long termThe long-term impact depends on whether the Rs 25 crore is deployed into high-margin expansions or used to stabilize the balance sheet against recent quarterly losses.
⚠ Risk flags
- Equity dilution for existing shareholders
- Recent earnings volatility (Sep 2025 loss of Rs 10.87 Cr)
- Execution risk regarding the deployment of new capital
Key Highlights
Issue of 7,93,650 warrants convertible into an equal number of equity shares
Minimum issue price fixed at Rs 315 per warrant
Total estimated fundraise value of approximately Rs 25 crore
In-principle approvals received from NSE and BSE on July 09, 2026
Allotment to be made to non-promoter investors on a preferential basis
👀 What to Watch
Investors should monitor the final allotment notification to identify the specific non-promoter investors and the subsequent disclosure regarding the utilization of these funds.
Halder Venture Approves FY26 Results & Proposes ₹1,000 Cr Borrowing Limit Increase
Halder Venture Limited has approved its audited financial results for the fiscal year ended March 31, 2026. A major highlight is the board's proposal to increase the company's borrowing limits and investment/loan limits to ₹1,000 crores each, pending shareholder approval. The company is also undergoing a statutory auditor transition, proposing P. Somani & Co. for a five-year term as the current auditor's tenure concludes. These structural and financial limit changes suggest the company is positioning itself for significant capital deployment or expansion.
Key Highlights
Approved standalone and consolidated audited financial results for the quarter and year ended March 31, 2026.
Proposed a significant increase in borrowing limits up to ₹1,000 crores under Section 180(1)(c).
Proposed increasing limits for providing loans, guarantees, and investments up to ₹1,000 crores under Section 186.
Recommended the appointment of M/s P. Somani & Co. as Statutory Auditors for a 5-year term starting from the 44th AGM.
Reappointed J Kumar Jain & Associates as Internal Auditors and J Pal & Co as Cost Auditors for FY 2026-27.
👀 What to Watch
Investors should closely monitor the specific reasons for the massive hike in borrowing limits to ₹1,000 crores, as this may precede a major acquisition or expansion phase. It is also essential to review the full audited financial report to evaluate the company's current debt-to-equity ratio before these new limits are utilized.
Halder Venture Approves FY26 Results; Proposes ₹1,000 Cr Borrowing & Investment Limit
Halder Venture Limited has approved its FY26 audited financial results and proposed a significant increase in its financial flexibility. The board has cleared an increase in borrowing limits to ₹1,000 Crores and a similar limit for loans and investments, pending shareholder approval. Additionally, the company is appointing P. Somani & Co. as the new Statutory Auditor for a five-year term following the completion of the previous auditor's tenure. These structural changes indicate a potential shift towards aggressive expansion or capital deployment in the near future.
Key Highlights
Approved standalone and consolidated audited financial results for the year ended March 31, 2026.
Proposed a substantial increase in borrowing limits up to ₹1,000 Crores under Section 180(1)(c).
Approved a limit of ₹1,000 Crores for providing loans, guarantees, and making investments under Section 186.
Recommended P. Somani & Co. as Statutory Auditor for a 5-year tenure starting from the 44th AGM.
Approved the reappointment of Internal and Cost Auditors for the Financial Year 2026-2027.
👀 What to Watch
Investors should monitor the specific utilization plans for the ₹1,000 Crore borrowing limit, as this suggests significant upcoming CAPEX or M&A activity. Review the full FY26 financial statements to assess the company's current leverage and profitability before the debt expansion.
Halder Venture FY26 Results: Proposes ₹1,000 Cr Borrowing Limit & New Auditor
Halder Venture Limited has approved its audited financial results for FY26 and is seeking shareholder approval for a massive expansion in financial capacity, raising borrowing and investment limits to ₹1,000 crores each. The company is appointing P. Somani & Co. as the new statutory auditor for a five-year term following the tenure completion of the previous auditor. An audit note highlighted a regulatory breach where subsidiaries hold 6.61% of the company's own shares, though a disposal process has initiated. This indicates a period of significant corporate restructuring and potential capital-intensive expansion.
Key Highlights
Proposed increase in borrowing limits to ₹1,000 crores to support future operations
Proposed investment and loan limits raised to ₹1,000 crores under Section 186 of the Companies Act
Appointment of P. Somani & Co. as Statutory Auditor for a 5-year term (2026-2031)
Audit report flagged 8,22,654 shares (6.61%) held by subsidiaries in violation of Section 19
Approved commission payment to Non-Executive Director Mrs. Poulomi Halder subject to shareholder approval
👀 What to Watch
Investors should monitor the specific deployment plan for the newly proposed ₹1,000 crore capital limit and track the progress of the subsidiary share disposal to ensure regulatory compliance.
Halder Venture Revises Valuation Report for Preferential Issue of 7.93 Lakh Warrants
Halder Venture Limited has submitted a revised valuation report for its proposed preferential issue of 7,93,650 convertible warrants. The revision was triggered by observations from the NSE and BSE, which classified the company's equity shares as "frequently traded shares." This classification requires a valuation update in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The update ensures regulatory compliance for the capital raising process initiated on May 13, 2026.
Key Highlights
Proposed preferential issue involves 7,93,650 Convertible Warrants.
Revision follows NSE and BSE classification of shares as 'frequently traded'.
Valuation updated to comply with Chapter V of SEBI ICDR Regulations.
The company has uploaded the full revised valuation report to its official website for transparency.
👀 What to Watch
Investors should check the revised valuation report on the company's website to see if the warrant pricing has changed. Monitor for further updates on the final allotment and the intended use of the raised capital.
Halder Venture Revises Compliance for Preferential Issue of 7.93 Lakh Warrants
Halder Venture Limited has submitted revised compliance documents regarding its proposed preferential issue of 7,93,650 convertible warrants. The revision follows observations from the National Stock Exchange (NSE) which led to the classification of the company's equity shares as "frequently traded shares." Consequently, the company has updated its Compliance Certificate to align with SEBI (Issue of Capital and Disclosure Requirements) Regulations. This procedural update is necessary to move forward with the planned capital infusion.
Key Highlights
Proposed preferential issue of 7,93,650 Convertible Warrants to raise capital.
NSE observations led to the reclassification of shares as "frequently traded shares."
Revised Compliance Certificate submitted to ensure adherence to SEBI ICDR Regulations.
The update follows a previous disclosure made on May 13, 2026.
👀 What to Watch
Investors should monitor the final pricing and conversion terms of the warrants, as the 'frequently traded' status may impact the valuation. No immediate action is required as this is a regulatory compliance update.
Halder Venture Updates Pricing Basis for 7.93 Lakh Warrant Issue Following NSE Observation
Halder Venture Limited has updated the classification of its equity shares from infrequently traded to frequently traded for its proposed preferential issue of 7,93,650 convertible warrants. This change follows observations from the National Stock Exchange (NSE) regarding SEBI ICDR Regulations. Despite the reclassification, the company confirmed that the issue price remains unchanged from the original postal ballot notice dated March 26, 2026. The pricing continues to be supported by a valuation report from a Registered Valuer under Regulation 166A.
Key Highlights
Proposed issuance of 7,93,650 convertible warrants on a preferential basis
Shares reclassified as frequently traded following NSE observation dated May 12, 2026
Issue price remains unchanged despite the change in trading frequency classification
Shareholder approval for the issue was previously secured via postal ballot on April 30, 2026
👀 What to Watch
Investors should note that the fundraising process is proceeding with regulatory alignment. No change in the issue price suggests that the valuation remains consistent with the registered valuer's assessment.
Halder Venture Shareholders Approve Capital Increase and Preferential Warrant Issue
Halder Venture Limited has received overwhelming shareholder approval for two major resolutions via postal ballot. The first resolution involves increasing the company's Authorized Share Capital, which passed with 99.9998% support. The second resolution, passed with 99.9973% support, authorizes the issuance of fully convertible warrants on a preferential basis to non-promoter entities. This indicates strong shareholder backing for the company's upcoming capital infusion and expansion plans.
Key Highlights
Resolution to increase Authorized Share Capital passed with 9,537,125 votes (99.9998%) in favor.
Issuance of fully convertible warrants to non-promoters approved with 9,536,878 votes (99.9973%) in favor.
A total of 79 members participated in the remote e-voting process which concluded on April 29, 2026.
The approval allows the company to proceed with preferential allotment to non-promoter categories for fund raising.
👀 What to Watch
Investors should monitor the specific pricing and allotment details of the convertible warrants to understand the extent of equity dilution and the profile of the new investors entering the company.
Halder Venture Issues 2nd Corrigendum for 7.93 Lakh Warrant Issue at ₹315
Halder Venture Limited has issued a second corrigendum to its postal ballot notice regarding the preferential issue of 7,93,650 convertible warrants. The issue price is fixed at ₹315 per warrant, which includes a premium of ₹305, based on an independent valuation of ₹314.79. This update follows observations from the National Stock Exchange (NSE) to ensure compliance with SEBI ICDR Regulations for infrequently traded shares. The proposed allotment will result in the allottee holding more than 5% of the post-issue fully diluted share capital.
Key Highlights
Preferential issue of 7,93,650 convertible warrants at a price of ₹315 per warrant.
Independent valuation report by CA Sanjay Jhajharia determined a floor price of ₹314.79.
Corrigendum issued to comply with SEBI ICDR Regulations 165 and 166A(1) following NSE observations.
The allotment will exceed 5% of the post-issue fully diluted share capital of the company.
Shareholders who have already voted can submit comments to the Company Secretary until April 26, 2026.
👀 What to Watch
Investors should review the valuation justification provided for this infrequently traded stock and monitor the impact of the 5% plus dilution on the capital structure. No immediate action is required unless shareholders wish to revise their feedback based on the new disclosures.
Halder Venture to Raise Rs 25 Cr via 7.94 Lakh Warrants for Haldia Unit Expansion
Halder Venture Limited is raising approximately Rs 25 crore through the issuance of 7,93,650 convertible warrants at Rs 315 per warrant to P.K. Bio Link Private Limited. The proceeds are primarily earmarked for a new 500 MT edible oil refining unit in Haldia (Rs 11.50 crore) and augmenting working capital (Rs 11.30 crore). The company also aims to increase its rice mill capacity utilization from 50% to 80% to serve expanding foreign markets. This corrigendum provides necessary clarifications on pricing and fund utilization as requested by NSE and BSE.
Key Highlights
Issuance of 7,93,650 convertible warrants at Rs 315 per warrant to raise ~Rs 25 crore.
Allocation of Rs 11.50 crore for a new 500 MT edible oil refining unit at the Haldia facility.
Plan to increase rice mill capacity utilization from 50% to 70-80% to meet export demand.
P.K. Bio Link Private Limited to hold a 5.99% stake in the company post-conversion.
Funds to be utilized within 6 months of receipt for capital expansion and working capital.
👀 What to Watch
Investors should track the execution of the Haldia refining unit as it marks a significant capacity expansion into the edible oil sector. Monitor the warrant conversion process over the next 18 months for potential equity dilution.
Halder Venture Credit Rating Upgraded to 'CRISIL BBB-/Stable' on Improved Financial Performance
CRISIL has upgraded Halder Venture Limited's long-term rating to 'CRISIL BBB-/Stable' from 'CRISIL BB+/Stable (Issuer Not Cooperating)' following improved data transparency and strong financial growth. The company reported a significant revenue jump to Rs 870.88 crore in FY25, with PAT nearly doubling to Rs 21.11 crore. While the group maintains a moderate financial risk profile with a gearing of 1.94x, it is currently executing a large Rs 155 crore capex for a new refinery and storage unit in Haldia. Liquidity is considered adequate with projected cash accruals of over Rs 22 crore against debt obligations of Rs 5 crore.
Key Highlights
Long-term credit rating upgraded to 'CRISIL BBB-/Stable' for Rs 387.27 crore bank facilities.
FY25 operating income grew to Rs 870.88 crore from Rs 646.19 crore in FY24.
Net profit (PAT) increased to Rs 21.11 crore in FY25 compared to Rs 11.67 crore in FY24.
Ongoing Rs 155 crore capex in Haldia for storage and refinery units, funded by Rs 75 crore debt.
Interest coverage ratio improved to 2.55 times in FY25 from 2.11 times in FY24.
👀 What to Watch
The rating upgrade and removal from the 'non-cooperating' category signal improved corporate governance and creditworthiness. Investors should monitor the timely commissioning of the Haldia refinery in 2027, as it is a key driver for future margin expansion.
